drugset / Trial / NCT01717157
A Study to Assess the Relative Bioavailability of 4 Formulations of Fentanyl Transdermal System Compared Against DUROGESIC Fentanyl Transdermal Patch After Single Application in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetics and relative bioavailability of 4 new formulations of fentanyl transdermal patch in healthy participants after a single application for 72 hours.
Timeline
- Start
- 2012-08
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | 6.2 mg | Topical |
| Subject | Fentanyl | Other / unclassified | 7.1 mg | Topical |
| Subject | Fentanyl | Other / unclassified | 8.4 mg | Topical |
| Subject | Fentanyl | Other / unclassified | 11 mg | Topical |
Indications
No indication recorded.